UNITEDHEALTH GROUP INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
UNH$405.12+1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Equity
| Common Stock · Additional Paid-In Capital · Retained Earnings · Accumulated Other Comprehensive Income (Loss) · NonredeemableNoncontrolling Interests · TotalEquity | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in millions, except per share data) · Shares · Amount · Net Unrealized Gains (Losses) on Investments · Foreign Currency Translation (Losses) Gains | |||||||||||||||
| Balance at January 1, 2021 | 946 | $10 | $— | $69,295 | $1,336 | $(5,150) | $2,837 | $68,328 | |||||||
| Net earnings | 17,285 | 360 | 17,645 | ||||||||||||
| Other comprehensive loss | (913) | (657) | (1,570) | ||||||||||||
| Issuances of common stock, and related tax effects | 8 | — | 1,100 | 1,100 | |||||||||||
| Share-based compensation | 729 | 729 | |||||||||||||
| Common share repurchases | (13) | — | (940) | (4,060) | (5,000) | ||||||||||
| Cash dividends paid on common shares ($5.60 per share) | (5,280) | (5,280) | |||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | (889) | (106) | (995) | ||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 407 | 407 | |||||||||||||
| Distributions to nonredeemable noncontrolling interests | (319) | (319) | |||||||||||||
| Balance at December 31, 2021 | 941 | 10 | — | 77,134 | 423 | (5,807) | 3,285 | 75,045 | |||||||
| Net earnings | 20,120 | 406 | 20,526 | ||||||||||||
| Other comprehensive (loss) gains | (3,201) | 192 | (3,009) | ||||||||||||
| Issuances of common stock, and related tax effects | 7 | — | 903 | 903 | |||||||||||
| Share-based compensation | 875 | 875 | |||||||||||||
| Common share repurchases | (14) | (1) | (1,892) | (5,107) | (7,000) | ||||||||||
| Cash dividends paid on common shares ($6.40 per share) | (5,991) | (5,991) | |||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | 114 | 114 | |||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 374 | 374 | |||||||||||||
| Distributions to nonredeemable noncontrolling interests | (387) | (387) | |||||||||||||
| Balance at December 31, 2022 | 934 | 9 | — | 86,156 | (2,778) | (5,615) | 3,678 | 81,450 | |||||||
| Net earnings | 22,381 | 575 | 22,956 | ||||||||||||
| Other comprehensive income | 807 | 559 | 1,366 | ||||||||||||
| Issuances of common stock, and related tax effects | 6 | — | 1,231 | 1,231 | |||||||||||
| Share-based compensation | 1,027 | 1,027 | |||||||||||||
| Common share repurchases | (16) | — | (2,057) | (6,002) | (8,059) | ||||||||||
| Cash dividends paid on common shares ($7.29 per share) | (6,761) | (6,761) | |||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | (201) | (201) | |||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 1,928 | 1,928 | |||||||||||||
| Distributions to nonredeemable noncontrolling interests | (516) | (516) | |||||||||||||
| Balance at December 31, 2023 | 924 | $9 | $— | $95,774 | $(1,971) | $(5,056) | $5,665 | $94,421 | |||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.